<VariationArchive VariationID="533332" VariationName="NC_000001.11:g.(?_45332568)_(45334517_?)del" VariationType="Deletion" Accession="VCV000533332" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2018-05-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="514857" VariationID="533332">
      <GeneList>
        <Gene Symbol="MUTYH" FullName="mutY DNA glycosylase" GeneID="4595" HGNC_ID="HGNC:7527" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45329242" stop="45340440" display_start="45329242" display_stop="45340440" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45794913" stop="45806141" display_start="45794913" display_stop="45806141" Strand="-" />
          </Location>
          <OMIM>604933</OMIM>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NC_000001.11:g.(?_45332568)_(45334517_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p34.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" innerStart="45332568" innerStop="45334517" display_start="45332568" display_stop="45334517" variantLength="1950" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" innerStart="45798240" innerStop="45800189" display_start="45798240" display_stop="45800189" variantLength="1950" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.(?_45332568)_(45334517_?)del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.(?_45332568)_(45334517_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.(?_45798240)_(45800189_?)del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.(?_45798240)_(45800189_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000001.11:g.(?_45332568)_(45334517_?)del AND Familial adenomatous polyposis 2" Accession="RCV000640421" Version="4">
        <ClassifiedConditionList TraitSetID="1473">
          <ClassifiedCondition DB="MedGen" ID="C3272841">Familial adenomatous polyposis 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-03-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-03-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-05-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12606733</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16557584</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17489848</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19732775</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21520333</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">23035301</ID>
          <ID Source="BookShelf">NBK107219</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1473" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1532" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="608456" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADENOMAS, MULTIPLE COLORECTAL, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="608456" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYH-associated polyposis</ElementValue>
                <Citation Type="review" Abbrev="Lindor, 2011">
                  <ID Source="PubMed">21325953</ID>
                </Citation>
                <XRef ID="MYH-associated+polyposis/8937" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FAP type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUTYH-associated polyposis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUTYH-related attenuated familial adenomatous polyposis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adenomas, multiple colorectal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial adenomatous polyposis 2</ElementValue>
                <XRef ID="MONDO:0012041" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FAP2</ElementValue>
                <XRef Type="MIM" ID="608456" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MAP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10805" />
                <XRef ID="10805" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">MUTYH polyposis (also referred to as MUTYH-associated polyposis, or MAP) is characterized by a greatly increased lifetime risk of colorectal cancer (CRC). Although typically associated with ten to a few hundred colonic adenomatous polyps, CRC develops in some individuals in the absence of polyposis. Serrated adenomas, hyperplastic/sessile serrated polyps, and mixed (hyperplastic and adenomatous) polyps can also occur. Duodenal adenomas are common, with an increased risk of duodenal cancer. The risk for malignancies of the ovary and bladder is also increased, and there is some evidence of an increased risk for breast and endometrial cancer. Additional reported features include thyroid nodules, benign adrenal lesions, jawbone cysts, and congenital hypertrophy of the retinal pigment epithelium.</Attribute>
                <XRef ID="NBK107219" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987420</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23035301</ID>
                <ID Source="BookShelf">NBK107219</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/ESMO, 2015">
                <ID Source="PubMed">25452455</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24310308</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Familial-Adenomatous-Polyposis-ACT-Sheet.aspx</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APC Pathogenic Variants (Familial Adenomatous Polyposis [FAP]), 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/cg118</URL>
                <CitationText>UK NICE Clinical Guideline CG118, Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <XRef ID="220460" DB="Orphanet" />
              <XRef ID="247798" DB="Orphanet" />
              <XRef ID="C3272841" DB="MedGen" />
              <XRef ID="MONDO:0012041" DB="MONDO" />
              <XRef Type="MIM" ID="608456" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1471747" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="NM_001128425.1_1_Deletion (exons 2-8)|MedGen:C1837991" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000762012" DateUpdated="2024-06-09" DateCreated="2018-05-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-03-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19732775</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21520333</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23035301</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12606733</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16557584</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17489848</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Tyr179 amino acid residue in MUTYH. Other variant(s) that disrupt this residue have been observed in affected individuals (PMID: 19732775, 21520333, 23035301, 12606733, 16557584, 17489848), suggesting that it is a clinically significant residue. As a result, variants that disrupt this residue are likely to be causative of disease This variant has not been reported in the literature in individuals with MUTYH-related disease. ClinVar contains an entry for this variant (Variation ID: 464717). This variant is a deletion of the genomic region encompassing exon 2-7 and part of exon 8 (c.37-1317_667del) of the MUTYH gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MUTYH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.(?_45798240)_(45800189_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1837991" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1471747" TraitType="Disease" MappingType="XRef" MappingValue="C1837991" MappingRef="MedGen">
        <MedGen CUI="C3272841" Name="Familial adenomatous polyposis 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

